Using f2 for compounds that never reach 85% dissolution [Dissolution / BCS / IVIVC]

posted by wligtenberg – The Netherlands, 2017-01-04 11:46 (3048 d 02:27 ago) – Posting: # 16928
Views: 6,493

❝ As the experts are apparently still on holiday :-) I might start with some questions/remarks.

❝ Liposomes with doxorubicin (just wild guessing here ;-) ) are no oral formulation afaik. Why would you do dissolution testing (simulation GI tract, normally)?


Wrong guess. :)

❝ The fraction of dose you get into solution pretty much depends on the media you use for your testing, in my opinion.

❝ So maybe some more details on the kind of products/projects your on might be helpful to get more response. :-)


In this case it is for eye drops. So some medium that resembles tears would make sense, right? So I do think that comparing dissolution makes sense in this case, even though it is not the GI tract.

That still leaves the issue that we will not reach 85% dissolution in that medium. And I do think we should not keep many time points from the plateau phase.

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
98 visitors (0 registered, 98 guests [including 10 identified bots]).
Forum time: 15:14 CEST (Europe/Vienna)

We should not speak so that it is possible
for the audience to understand us,
but so that it is impossible
for them to misunderstand us.    Quintilian

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5